Works matching IS 00070920 AND DT 2024 AND VI 131 AND IP 6

Results: 17
    1
    2

    CDK9 inhibition inhibits multiple oncogenic transcriptional and epigenetic pathways in prostate cancer.

    Published in:
    British Journal of Cancer, 2024, v. 131, n. 6, p. 1092, doi. 10.1038/s41416-024-02810-8
    By:
    • Rahman, Razia;
    • Rahaman, Muhammed H.;
    • Hanson, Adrienne R.;
    • Choo, Nicholas;
    • Xie, Jianling;
    • Townley, Scott L.;
    • Shrestha, Raj;
    • Hassankhani, Ramin;
    • Islam, Saiful;
    • Ramm, Susanne;
    • Simpson, Kaylene J.;
    • Risbridger, Gail P.;
    • Best, Giles;
    • Centenera, Margaret M.;
    • Balk, Steven P.;
    • Kichenadasse, Ganessan;
    • Taylor, Renea A.;
    • Butler, Lisa M.;
    • Tilley, Wayne D.;
    • Conn, Simon J.
    Publication type:
    Article
    3
    4

    Copy number alterations in metastatic and early breast tumours: prognostic and acquired biomarkers of resistance to CDK4/6 inhibitors.

    Published in:
    British Journal of Cancer, 2024, v. 131, n. 6, p. 1060, doi. 10.1038/s41416-024-02804-6
    By:
    • Sablin, Marie-Paule;
    • Gestraud, Pierre;
    • Jonas, Sarah Flora;
    • Lamy, Constance;
    • Lacroix-Triki, Magali;
    • Bachelot, Thomas;
    • Filleron, Thomas;
    • Lacroix, Ludovic;
    • Tran-Dien, Alicia;
    • Jézéquel, Pascal;
    • Mauduit, Marjorie;
    • Barros Monteiro, Janice;
    • Jimenez, Marta;
    • Michiels, Stefan;
    • Attignon, Valery;
    • Soubeyran, Isabelle;
    • Driouch, Keltouma;
    • Servant, Nicolas;
    • Le Tourneau, Christophe;
    • Kamal, Maud
    Publication type:
    Article
    5
    6
    7
    8

    Characteristics and outcome of synchronous bilateral Wilms tumour in the SIOP WT 2001 Study: Report from the SIOP Renal Tumour Study Group (SIOP-RTSG).

    Published in:
    British Journal of Cancer, 2024, v. 131, n. 6, p. 972, doi. 10.1038/s41416-024-02799-0
    By:
    • Sudour-Bonnange, Hélène;
    • van Tinteren, Harm;
    • Ramírez-Villar, Gema L.;
    • Godzinski, Jan;
    • Irtan, Sabine;
    • Gessler, Manfred;
    • Chowdhury, Tanzina;
    • Audry, Georges;
    • Fuchs, Joerg;
    • Powis, Mark;
    • van de Ven, Cornelis P.;
    • Okoye, Bruce;
    • Smeulders, Naima;
    • Vujanic, Gordan M.;
    • Verschuur, Arnaud;
    • L'Herminé-Coulomb, Aurore;
    • de Camargo, Beatriz;
    • de Aguirre Neto, Joaquim Caetano;
    • Schenk, Jens Peter;
    • van den Heuvel-Eibrink, Mary M.
    Publication type:
    Article
    9

    COLUMBIA-1: a randomised study of durvalumab plus oleclumab in combination with chemotherapy and bevacizumab in metastatic microsatellite-stable colorectal cancer.

    Published in:
    British Journal of Cancer, 2024, v. 131, n. 6, p. 1005, doi. 10.1038/s41416-024-02796-3
    By:
    • Segal, Neil H.;
    • Tie, Jeanne;
    • Kopetz, Scott;
    • Ducreux, Michel;
    • Chen, Eric;
    • Dienstmann, Rodrigo;
    • Hollebecque, Antoine;
    • Reilley, Matthew J.;
    • Elez, Elena;
    • Cosaert, Jan;
    • Cain, Jason;
    • Soo-Hoo, Yee;
    • Hewson, Nicola;
    • Cooper, Zachary A.;
    • Kumar, Rakesh;
    • Tabernero, Josep
    Publication type:
    Article
    10
    11

    Pre-diagnosis tea and coffee consumption and survival after a diagnosis of ovarian cancer: results from the Ovarian Cancer Association Consortium.

    Published in:
    British Journal of Cancer, 2024, v. 131, n. 6, p. 1043, doi. 10.1038/s41416-024-02792-7
    By:
    • Nagle, Christina M.;
    • Ibiebele, Torukiri I.;
    • Bandera, Elisa V.;
    • Cramer, Daniel;
    • Doherty, Jennifer A.;
    • Giles, Graham G.;
    • Goodman, Marc T.;
    • Hanley, Gillian E.;
    • Harris, Holly R.;
    • Jensen, Allan;
    • Kjaer, Susanne K.;
    • Lee, Alice W.;
    • Milne, Roger L.;
    • Qin, Bo;
    • Richardson, Jean;
    • Sasamoto, Naoko;
    • Sieh, Weiva;
    • Terry, Kathryn L.;
    • Titus, Linda;
    • Trabert, Britton
    Publication type:
    Article
    12
    13
    14
    15
    16
    17